Characteristics | Number of Registrants | Percentage |
---|---|---|
Age | ||
 11–15 | 865 | 0.3 |
 16–19 | 1654 | 0.6 |
 20–29 | 20,130 | 7.1 |
 30–39 | 30,492 | 10.7 |
 40–49 | 34,678 | 12.2 |
 50–59 | 52,509 | 18.5 |
 60–69 | 58,775 | 20.7 |
 70–79 | 55,791 | 19.7 |
 80–89 | 25,457 | 9.0 |
 90+ | 3440 | 1.2 |
Sex | ||
 Female | 170,459 | 60.1 |
 Male | 113,332 | 39.9 |
Disease status | ||
 Any malignancy | 20,124 | 7.1 |
 Cerebrovascular disease | 8734 | 3.1 |
 Chronic pulmonary disease | 22,454 | 7.9 |
 Congestive heart failure | 5329 | 1.9 |
 Dementia | 881 | 0.3 |
 Diabetes with chronic complication | 1571 | 0.6 |
 Diabetes without chronic complication | 18,476 | 6.5 |
 Hemiplegia or paraplegia | 1481 | 0.5 |
 Metastatic solid tumour | 4329 | 1.5 |
 Mild liver disease | 4575 | 1.6 |
 Moderate or severe liver disease | 1255 | 0.4 |
 Myocardial infarction | 9252 | 3.3 |
 Peptic ulcer disease | 4152 | 1.5 |
 Peripheral vascular disease | 5495 | 1.9 |
 Renal disease | 7449 | 2.6 |
 Rheumatic disease | 4862 | 1.7 |
Medication type | Â | 0.0 |
 Analgesics | 86,839 | 30.6 |
 Antidiabetic Drugs | 27,042 | 9.5 |
 Antidepressant | 72,201 | 25.4 |
 Antihypertensives | 89,418 | 31.5 |
 Cardiovascular System | 144,363 | 50.9 |
 Central Nervous System | 130,106 | 45.8 |
 Endocrine System | 80,870 | 28.5 |
 Gastro-Intestinal System | 170,990 | 60.3 |
 Infections | 92,156 | 32.5 |
 Inhaled Steroids | 29,588 | 10.4 |
 Lipid Modifying Drugs | 67,433 | 23.8 |
 Muscoskeletal And Joint Disease | 67,483 | 23.8 |
 NSAIDs including Cox-2 | 35,408 | 12.5 |
 Respiratory System | 65,127 | 22.9 |
 Skin | 71,544 | 25.2 |
 Topical Steroids | 43,186 | 15.2 |